# Village Farms Pilots Potency Range Labeling in Canada > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/potency-range-labeling-cannabis-village-farms-pilot/ > **Published:** 2026-04-10T15:11:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:00-04:00 > **Clinical Summary:** Village Farms pilots potency range labeling cannabis products in Canada, improving accuracy and patient dosing expectations with realistic THC ranges. --- ✦ New CED Clinical Relevance  #78Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic DosingProduct Quality[Patient Education](https://cedclinic.com/medical-cannabis-patient-education-basics/)RegulationThc Why This Matters Potency range labeling represents a shift from precise THC/CBD percentages to ranges that better reflect natural variation in cannabis products. This addresses a fundamental disconnect between regulatory precision and biological reality that affects patient dosing accuracy and expectations. Clinical Summary Village Farms is piloting potency range labeling in Canada, moving away from specific cannabinoid percentages to ranges that account for natural variation in cannabis products. Traditional precise labeling (e.g., 18.5% THC) creates false precision when actual potency can vary significantly within batches due to storage, handling, and plant biology. Range labeling (e.g., 16-20% THC) better represents the actual variability patients encounter while maintaining regulatory compliance and consumer information. Dr. Caplan’s Take “This is long overdue — we’ve been giving patients false precision for years. When I prescribe cannabis, I always counsel patients that the labeled percentage is approximate, not gospel, because the plant doesn’t read the label.” Clinical Perspective 🧠 Clinicians should prepare patients for this transition by emphasizing that [cannabis dosing](https://cedclinic.com/medical-cannabis-safety-facts/) requires individual titration regardless of labeling precision. Range labeling may actually improve patient outcomes by setting more realistic expectations about product consistency and encouraging proper dose adjustment rather than relying on seemingly precise numbers that don’t reflect biological reality. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Village%20Farms%20Pilots%20Potency%20Range%20Labeling%20in%20Canada%20%7C%20Cannabis%20Business%20Times%20%40drcaplan&url=https%3A//www.cannabisbusinesstimes.com/packaging-branding/cannabis-product-labeling/news/15821914/village-farms-pilots-potency-range-labeling-in-canada)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.cannabisbusinesstimes.com/packaging-branding/cannabis-product-labeling/news/15821914/village-farms-pilots-potency-range-labeling-in-canada)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Village%20Farms%20Pilots%20Potency%20Range%20Labeling%20in%20Canada%20%7C%20Cannabis%20Business%20Times%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.cannabisbusinesstimes.com/packaging-branding/cannabis-product-labeling/news/15821914/village-farms-pilots-potency-range-labeling-in-canada)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.cannabisbusinesstimes.com/packaging-branding/cannabis-product-labeling/news/15821914/village-farms-pilots-potency-range-labeling-in-canada](https://www.cannabisbusinesstimes.com/packaging-branding/cannabis-product-labeling/news/15821914/village-farms-pilots-potency-range-labeling-in-canada) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news update?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news_update) - [What key areas does this cannabis clinical update cover?](#What_key_areas_does_this_cannabis_clinical_update_cover) - [Why is this classified as “Notable Clinical Interest”?](#Why_is_this_classified_as_8220Notable_Clinical_Interest8221) - [What type of healthcare professionals should review this update?](#What_type_of_healthcare_professionals_should_review_this_update) - [How should clinicians use this information in practice?](#How_should_clinicians_use_this_information_in_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news update? This update has been assigned CED Clinical Relevance #78 with a “Notable Clinical Interest” classification. This indicates emerging findings or policy developments that healthcare professionals should monitor closely. #### What key areas does this cannabis clinical update cover? The update focuses on four main areas: dosing guidelines, product quality standards, [patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/) materials, and regulatory developments. These represent critical components of [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) practice. #### Why is this classified as “Notable Clinical Interest”? This classification suggests the information contains emerging findings or policy developments that could impact clinical practice. Healthcare providers should pay close attention to these developments as they may influence treatment protocols. #### What type of healthcare professionals should review this update? This update is primarily intended for clinicians working with [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/), including physicians, pharmacists, and other healthcare providers involved in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs. The clinical relevance rating indicates it’s particularly important for those actively treating patients with cannabis-based medicines. #### How should clinicians use this information in practice? Clinicians should monitor these developments closely as they may influence dosing decisions, product selection, patient counseling approaches, and compliance with evolving regulations. The information should be integrated into clinical decision-making processes as appropriate. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Village Farms pilots THC potency range labelling in BC – StratCann](https://cedclinic.com/thc-potency-range-labeling-bc-village-farms-pilot/) Explore how Village Farms is implementing THC potency range labeling in British Columbia to improve product transparency and consumer trust. [Read More](https://cedclinic.com/thc-potency-range-labeling-bc-village-farms-pilot/) [Massachusetts Regulators Initiate Audits of Cannabis THC Potency Levels – Hemp Gazette](https://cedclinic.com/cannabis-thc-potency-regulation-ct-bill-update/) Learn about regulatory audits in Massachusetts focusing on cannabis THC potency levels and their impact on product quality standards. [Learn More](https://cedclinic.com/cannabis-thc-potency-regulation-ct-bill-update/) [Colorado cannabis regulators promise crackdown on hemp THC inversion – MJBizDaily](https://cedclinic.com/hemp-regulation-product-safety-colorado-thc-inversion-crackdown/) Discover Colorado's regulatory efforts to address hemp THC inversion issues and ensure accurate cannabis product labeling. [Discover More](https://cedclinic.com/hemp-regulation-product-safety-colorado-thc-inversion-crackdown/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).